PT-141 (Bremelanotida) vs Kisspeptina
PT-141 (Bremelanotida) is mainly studied for libido, sexual response (male and female). while Kisspeptina is studied for vitality, reproductive-axis signaling. The difference is in the mechanism and the evidence, not in which is "better": it depends on the goal.
| PT-141 (Bremelanotida) | Kisspeptina | |
|---|---|---|
| Category | Hormonal/Sexual | Hormonal/Sexual |
| Studied for | Libido, sexual response (male and female). | Vitality, reproductive-axis signaling. |
| How it acts | A peptide studied for its relationship with melanocortin pathways in the central nervous system, associated with sexual-desire response. | A peptide studied for its relationship with regulation of the reproductive axis and upstream hormonal signaling. |
| Evidence level | Human trials available | Human trials available |
How they differ
Although sometimes mentioned together, PT-141 (Bremelanotida) and Kisspeptina do not target the same thing. PT-141 (Bremelanotida): A peptide studied for its relationship with melanocortin pathways in the central nervous system, associated with sexual-desire response. Kisspeptina: A peptide studied for its relationship with regulation of the reproductive axis and upstream hormonal signaling.
See full entry: PT-141 (Bremelanotida) → · See full entry: Kisspeptina →
Want to truly understand it, not memorize it?
The course explains each peptide at a university level: how it acts, what outcomes are studied, what it combines with and when to pause. No doses: the protocol is defined by a professional.
See the course → Start with the free test →Frequently asked questions
What is the main difference between PT-141 (Bremelanotida) and Kisspeptina?
PT-141 (Bremelanotida) targets libido, sexual response (male and female). and Kisspeptina targets vitality, reproductive-axis signaling. They act through different pathways, so the choice depends on your goal, not on which is "stronger".
Can they be studied together?
Combinations are studied by goal in the literature, but combining is not just adding: it changes the safety profile. What to combine and how is decided with a professional; here we only explain what each is studied for.
Which has more human evidence?
Based on the references we verified, PT-141 (Bremelanotida) has more human studies of this pair. Each one's evidence level is in the table above, and the references with their PMID are at the end.
Was this page useful?
Research moves, and when something relevant changes we update the page. If you want to hear about it for PT-141 (Bremelanotida) vs Kisspeptina or any other compound, leave your email. The introductory guide comes with it. No spam, no list-selling; one click to unsubscribe.
References
Every entry links to its record on PubMed, the US National Library of Medicine database. Open them and check. We would rather have a reader who verifies than one who takes our word for it.
- Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.human Obstet Gynecol · 2019 · PMID 31599840 →
- Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder.human Obstet Gynecol · 2019 · PMID 31599847 →
- Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide.human J Womens Health (Larchmt) · 2022 · PMID 35230162 →
- The Patient Experience of Premenopausal Women Treated with Bremelanotide for Hypoactive Sexual Desire Disorder: RECONNECT Exit Study Results.human J Womens Health (Larchmt) · 2021 · PMID 33538638 →
- Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis.human J Clin Endocrinol Metab · 2009 · PMID 19820030 →
- Increasing LH pulsatility in women with hypothalamic amenorrhoea using intravenous infusion of Kisspeptin-54.human J Clin Endocrinol Metab · 2014 · PMID 24517142 →
- Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy.human J Clin Endocrinol Metab · 2015 · PMID 26192876 →
- A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial.human Hum Reprod · 2017 · PMID 28854728 →
Educational content. It does not include doses, protocols or preparation: that is defined by a professional.